Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nateglinide vs Acarbose in Chinese Drug-naive T2DM
NCT00928889Phase 4Completed
- Sponsor
- Novartis
- Start
- Jul 2009
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nateglinide in type 2 diabetes mellitus (T2DM), sponsored by Novartis. Started Jul 2009; status: completed.
02
Drugs
nateglinide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00928889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00928889.